Strangvac

País: Unión Europea

Idioma: noruego

Fuente: EMA (European Medicines Agency)

Ingredientes activos:

Recombinant Streptococcus equi protein CCE, Recombinant Streptococcus equi protein Eq85, Recombinant Streptococcus equi protein IdeE

Disponible desde:

Intervacc AB

Código ATC:

QI05AB01

Designación común internacional (DCI):

Streptococcus equi vaccine (recombinant proteins)

Grupo terapéutico:

hester

Área terapéutica:

Immunologier for hovdyr

indicaciones terapéuticas:

For the active immunisation to reduce clinical signs and the number of abscesses in acute stage of infection with S. equi.

Estado de Autorización:

autorisert

Fecha de autorización:

2021-08-16

Información para el usuario

OFFICIAL ADDRESS
Domenico Scarlattilaan 6
●
1083 HS Amsterdam
●
The Netherlands
An agency of the European Union
ADDRESS FOR VISITS AND DELIVERIES
Refer to www.ema.europa.eu/how-to-find-us
SEND US A QUESTION
Go to
www.ema.europa.eu/contact
TELEPHONE
[phone]
6000
© European Medicines Agency,
2023. Reproduction is authorised provided the source is acknowledged.
Oppdaterte opplysninger om dette legemidlet til dyr er tilgjengelige
på informasjonsnettstedet for
legemidler til dyr.

Ficha técnica

OFFICIAL ADDRESS
Domenico Scarlattilaan 6
●
1083 HS Amsterdam
●
The Netherlands
An agency of the European Union
ADDRESS FOR VISITS AND DELIVERIES
Refer to www.ema.europa.eu/how-to-find-us
SEND US A QUESTION
Go to
www.ema.europa.eu/contact
TELEPHONE
[phone]
6000
© European Medicines Agency,
2023. Reproduction is authorised provided the source is acknowledged.
Oppdaterte opplysninger om dette legemidlet til dyr er tilgjengelige
på informasjonsnettstedet for
legemidler til dyr.